Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123254) titled 'The Influence of Treatment Methods and Tumor Burden on the Prognosis of Metastatic Prostatic Acinar Carcinom' on April 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Zibo Central Hospital
Condition:
Prostate cancer
Intervention:
Pure ADT group (Only received castration therapy (surgical castration or medical castration), without combining any other systemic treatments
):None
ADT+ARPI (ADT combined with new endocrine drugs (abiraterone, enzalutamide, darolutamide, etc.), with standardized medication use and no serious medication adherence issues during follow-up
):None
ADT + ...